Myeloproliferative disorders (MPD) - CML - Chronic myeloid leukemia
''Myeloproliferative disorders(MPD) are relatively rare chronic hematologic malignancies that include the classic myeloproliferative disorders:
Philadelphia chromosome-negative Philadelphia chromosome-positive
Essential Thrombocythemia (ET) Chronic Myelogenous Leukemia (CML)
Myelofibrosis (MF)
Polycythemia Vera (PV)
There are atypical myeloproliferative disorders which include molecularly defined PDGFRA-rearranged eosinophilic/mast cell disorders; PDGFRB-rearranged eosinophilic disorders; systemic mastocytosis associated with c-kit mutation; 8p11 Myeloproliferative syndrome; and juvenile myelomonocytic leukemia with recurrent mutations of RAS. MPD also includes the clinicopathologically assigned variants: chronic neutrophilic leukemia; chronic eosinophilic leukemia; hypereosinophillic syndrome, chronic basophilic leukemia, chronic monomyelomonocytic leukemia, systemic mastocytosis; and unclassified myeloproliferative disorder. Chronic myeloid disorders also include myelodysplastic syndrome.''
Extract of MPD INFO
ARTICLES
Update on CML-Like Disorders
September 2020, Clinical Lymphoma Myeloma & Leukemia
A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow
June 2014, NCBI
Risk of second cancers in chronic myeloproliferative neoplasms.
April 19, 2012, PubLMed
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells
January 11, 2007, Nature
Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era
2006, American Society of Hematology
Update on CML-Like Disorders
September 2020, Clinical Lymphoma Myeloma & Leukemia
A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow
June 2014, NCBI
Risk of second cancers in chronic myeloproliferative neoplasms.
April 19, 2012, PubLMed
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells
January 11, 2007, Nature
Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era
2006, American Society of Hematology